SCHEMBL5924447

SCHEMBL5924447

Nc1cc(F)c(N2C(=O)c3ccccc3C2=O)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ ANPEP P15144 2/20 0.46
▸ DPP4 P27487 2/20 0.46
▸ SCN2A Q99250 2/20 0.41
▸ GRM1 Q13255 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ HSPA1A P0DMV8 1/20 0.39
▸ PABPC1 P11940 1/20 0.39
▸ TSHR P16473 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CASP1 P29466 1/20 0.38
▸ RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10622839 0.80 POLB (0.46) DPP4KMT2AMEN1TSHR
SCHEMBL5924351 0.79 CYP3A4 (0.66) CYP3A4NFKB1PMP22ANPEPDPP4
SCHEMBL5924386 0.76 SCN2A (0.57) SCN2AKMT2AMEN1CA12CA1
SCHEMBL24195812 0.76 HTT (0.49) SCN2AKMT2AMEN1CA12CA1
SCHEMBL6794921 0.75 MEN1 (0.46) CYP3A4NFKB1PMP22ANPEPDPP4
SCHEMBL5391376 0.72 SCN2A (0.43) CYP3A4NFKB1PMP22ANPEPDPP4
SCHEMBL29654372 0.69 CYP3A4 (0.40) CYP3A4NFKB1PMP22SCN2AKMT2A
SCHEMBL24525255 0.69 CYP3A4 (0.40) CYP3A4NFKB1PMP22SCN2AKMT2A
SCHEMBL1974304 0.68 KMT2A (0.64) CYP3A4NFKB1PMP22SCN2AKMT2A
SCHEMBL7751815 0.68 MGLL (0.61) CYP3A4NFKB1PMP22KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060270628-A1 Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES, INC. 2006-11-30 — — US disclosed
WO-2004101531-A1 ANTIINFECTIVE 1,2,3-TRIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM DR. REDDY'S LABORATORIES LTD. (IN) 2004-11-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060270628-A1 Antiinfective 1,2,3-triazole derivatives, process for their preparation and pharmaceutical compositions containing them IL33, IL5, IL1B CYP3A4 67/4885NFKB1 157/4885PMP22 4690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback